Study of GPCR–Protein Interactions by BRET
Bioluminescence resonance energy transfer (BRET) has become an extremely valuable technology for the real-time study of protein–protein interactions in live cells. This technique is highly amenable to the monitoring of G protein-coupled receptor (GPCR)–protein interactions, especially involving scaffolding, regulatory and signaling proteins, such as β-arrestins, which are now known to have significant roles in addition to receptor desensitization. The BRET procedure utilizes heterologous coexpression of fusion proteins linking one protein of interest (e.g. a GPCR) to a bioluminescent donor enzyme, a variant of Renilla luciferase, and a second protein of interest (e.g. β-arrestin) to an acceptor fluorophore. If in close proximity, energy resulting from the rapid oxidation of a cell-permeable coelenterazine substrate by the donor will transfer to the acceptor, which in turn fluoresces at a longer characteristic wavelength. Therefore, the occurrence of such energy transfer implies that the proteins of interest fused to the donor and acceptor interact directly or as part of a complex. BRET detection can be carried out using scanning spectrometry or dual-filter luminometry. The latest improvements in BRET methodology have enabled live cell drug screening as well as monitoring of previously undetectable protein-protein complexes, including constitutive GPCR/β-arrestin interactions. Therefore, BRET is likely to play an increasingly important role in GPCR research and drug discovery over the coming years.
Key wordsBioluminescence resonance energy transfer G protein-coupled receptor Arrestin Renilla luciferase8 Rluc8 Fluorophore Venus
KDGP’s work using the BRET methodology is funded by the National Health and Medical Research Council (NHMRC) of Australia (Project Grant #566736). KDGP is an Australian Research Council (ARC) Future Fellow (FT100100271).
- 5.Kocan M., See H. B., Sampaio N. G., Eidne K. A., Feldman B. J., and Pfleger K. D. G. (2009) Agonist-independent interactions between β-arrestins and mutant vasopressin type II receptors associated with nephrogenic syndrome of inappropriate antidiuresis. Mol. Endocrinol. 23, 559–571.PubMedCrossRefGoogle Scholar
- 23.Jaeger, W. C., Pfleger, K. D. G., and Eidne, K. A. Monitoring GPCR-protein complexes using bioluminescence resonance energy transfer, in G Protein Coupled Receptors: Essential Methods (Poyner, D. and Wheatley, M., ed.), John Wiley & Sons, Hoboken, NJ, 111–132.Google Scholar